Commentary on Bansback et al. (2018): Estimating the cost of stigma against injection.
Saved in:
| Title: | Commentary on Bansback et al. (2018): Estimating the cost of stigma against injection. |
|---|---|
| Authors: | Linas, Benjamin P. |
| Source: | Addiction. Jul2018, Vol. 113 Issue 7, p1274-1275. 2p. |
| Subjects: | Crime prevention, Substance abuse & psychology, Cost effectiveness, Health services accessibility, Heroin, Medical care costs, Health policy, Methadone hydrochloride, Morphine, Narcotics, Oral drug administration, Quality of life, Social stigma, Substance abuse, Uncertainty, Treatment effectiveness |
| Abstract: | The author reflects on the long term costs and outcomes of hydromorphone therapy or diacetylmorphine therapy to treat severe opioid use disorder compared to methadone therapy. He states over the long term there is lower costs and better outcomes for both injectable treatments than methadone maintenance. He mentions that reduced criminal activity is responsible for much of the cost savings from injectable therapy and talks about how stigma is the chief barrier to injectable opioid therapy. |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | The author reflects on the long term costs and outcomes of hydromorphone therapy or diacetylmorphine therapy to treat severe opioid use disorder compared to methadone therapy. He states over the long term there is lower costs and better outcomes for both injectable treatments than methadone maintenance. He mentions that reduced criminal activity is responsible for much of the cost savings from injectable therapy and talks about how stigma is the chief barrier to injectable opioid therapy. |
|---|---|
| ISSN: | 09652140 |
| DOI: | 10.1111/add.14219 |
